Anti-inflammatory therapeutic approaches to reduce acute atherosclerotic complications

Isabella Kanzler1, Elisa A Liehn, Rory R Koenen

  • 1Institute for Molecular Cardiovascular Research,Interdisciplinary Center for Clinical Research Aachen, RWTH Aachen University, Germany.

Insights

Chemokines play a key role in cardiovascular diseases like atherosclerosis and heart attack. Targeting chemokine pathways offers promising therapeutic strategies for these major causes of death.

Area of Science:

  • Cardiovascular Science
  • Immunology
  • Pharmacology

Background:

  • Cardiovascular diseases (CVDs) are a leading cause of mortality in Western countries.
  • Chemokines are critical regulators of leukocyte migration and function, influencing CVD initiation and progression.
  • Current research focuses on targeting chemokine pathways for therapeutic interventions.

Purpose of the Study:

  • To review the role of chemokines in cardiovascular diseases.
  • To evaluate the therapeutic potential of modulating chemokine pathways.
  • To highlight considerations for future drug development targeting chemokines in CVDs.

Main Methods:

  • Review of existing studies on chemokine antagonism and receptor blockade in cardiovascular pathology.
  • Analysis of specific chemokine pathways (CCL2/CCR2, CCL5/CCR1-CCR5, CXCL12/CXCR4).
  • Consideration of various modulation strategies: receptor-ligand interaction, chemokine-glycosaminoglycan interaction, heteromerization, and signaling interference.

Main Results:

  • Modulating chemokine pathways shows significant potential for cardiovascular drug development.
  • Targeting specific chemokine-receptor interactions offers therapeutic avenues.
  • Understanding the impact of combined chemokine expression is crucial.

Conclusions:

  • Chemokine modulation represents a promising therapeutic strategy for cardiovascular diseases.
  • Future drug development must consider the complex interplay of multiple chemokines.
  • Careful scrutiny of therapeutic strategies is essential for effective CVD treatment.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...